These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 49865)

  • 1. [Treatment of malignant lymphomas with shock doses of peptichemio].
    Battelli T; Bonsignori M; Manocchi P
    Minerva Med; 1975 Jun; 66(43):2087-93. PubMed ID: 49865
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings: Malignant lymphoma: treatment with combination chemotherapy.
    De Vita VT; Canellos GP; Schein PJ; Chabner BA; Bagley CM; Young RC
    Proc Natl Cancer Conf; 1972; 7():379-90. PubMed ID: 4587651
    [No Abstract]   [Full Text] [Related]  

  • 3. [Combination chemotherapy and synchronization therapy in lymphogranulomatosis and non-Hodgkin's lymphomas].
    Klein HO
    Hamatol Bluttransfus; 1976; 18():135-45. PubMed ID: 786808
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination chemotherapy of advanced, diffuse, non-Hodgkin's lymphoma: results with cyclo-phosphamide, adriamycin, vincristine, prednisone, and bleomycin (CHOP-Bleo).
    Case DC
    J Maine Med Assoc; 1979 Sep; 70(9):348-50, 352, 368. PubMed ID: 92513
    [No Abstract]   [Full Text] [Related]  

  • 5. [Malignant lymphoma].
    Streuli RA
    Schweiz Rundsch Med Prax; 1981 May; 70(20):909-15. PubMed ID: 7015304
    [No Abstract]   [Full Text] [Related]  

  • 6. [Polychemotherapy of lymphomas. Results of a selection of 32 cases diagnosed in stage III and stage IV and not previously treated].
    Neretto G; Giovanelli E; Agricola R; Furno F
    Minerva Med; 1978 Oct; 69(49):3367-71. PubMed ID: 724146
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of non-Hodgkin lymphomas].
    Izzi T; Porcellini A; Delfini C; Lucarelli G
    Minerva Med; 1982 Apr; 73(15):949-53. PubMed ID: 7078792
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chemotherapy of malignant lymphomas].
    Brücher H
    Med Welt; 1978 Oct; 29(40):1563-9. PubMed ID: 360002
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug therapy of malignant lymphoma].
    Ogawa M; Inagaki J
    Rinsho Hoshasen; 1985 Oct; 30(11):1317-32. PubMed ID: 2418229
    [No Abstract]   [Full Text] [Related]  

  • 10. Trichlortriethylamine (TS-160 Spofa) in combination chemotherapy of malignant lymphomas.
    Klener P; Donner L
    Neoplasma; 1975; 22(1):55-62. PubMed ID: 1097949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotherapy in non-Hodgkin's lymphomas (author's transl)].
    Schmidt CG
    Strahlentherapie; 1977 May; 153(5):283-92. PubMed ID: 69343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined therapy with bleomycin and some immunological implications.
    Barduagni A; Marolla A; Calabresi F; Terzoli E
    Prog Biochem Pharmacol; 1976; 11():185-94. PubMed ID: 63963
    [No Abstract]   [Full Text] [Related]  

  • 13. Long term experience with combination chemotherapy in advanced Hodgkin's disease.
    Garrett MJ; Das S; Smith JD; Freedman LS
    Clin Oncol; 1977 Jun; 3(2):145-54. PubMed ID: 68843
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical trials with intensive chemotherapy and radiotherapy in Hodgkin's disease.
    De Lena M; Monfardini S; Beretta G; Fossati-Bellani F; Bonadonna G
    Natl Cancer Inst Monogr; 1973 May; 36():403-20. PubMed ID: 4126720
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of recurrent lymphomas with vincristine, BCNU, doxorubicin, and prednisone (VBAP): a Southwest Oncology Group Study.
    Weick JK; Jones SE; Haut A; Fisher R; Dixon D
    Cancer Treat Rep; 1981; 65(7-8):611-4. PubMed ID: 6166373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy of advanced malignant lymphomas comparative evaluation of results with single agent and combination therapy.
    Klener P; Donner L; Roth Z
    Neoplasma; 1976; 23(3):315-22. PubMed ID: 958533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study.
    Longo DL; Duffey PL; Gribben JG; Jaffe ES; Curti BD; Gause BL; Janik JE; Braman VM; Esseltine D; Wilson WH; Kaufman D; Wittes RE; Nadler LM; Urba WJ
    Cancer J; 2000; 6(3):146-50. PubMed ID: 10882329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CCNU, bleomycin, and vincristine (vinblastine) combination therapy in the treatment of resistant lymphoma (author's transl)].
    García López J; Diumenjo MC; Argüelles MV; Marín P; Grañena A; Montserrat E; Rozman C
    Sangre (Barc); 1980; 25(6):1014-21. PubMed ID: 6164107
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemotherapy of the lymphomas.
    Todd ID
    Proc R Soc Med; 1970 Jan; 63(1):86-8. PubMed ID: 5417792
    [No Abstract]   [Full Text] [Related]  

  • 20. Experience in the treatment of malignant lymphomas.
    Bláha M; Vanásek J; Mazák J; Matĕja F
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1976; 19(3-4):287-96. PubMed ID: 1072522
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.